Archives
- 2026-09
- 2026-08
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
-
Pleuromutilin Binding at the Ribosomal PTC
2026-09-08
Long et al. combined chemical footprinting with an Escherichia coli L3 mutant model to clarify how tiamulin and related pleuromutilins engage the ribosomal peptidyl transferase center. The study separates conserved interactions made by the mutilin core from adaptable side-chain contacts, providing a mechanistic basis for designing derivatives that retain activity against altered ribosomal binding surfaces.
-
Rottlerin PKC Inhibitor: Assay Workflows
2026-09-07
Rottlerin provides a practical PKC inhibitor framework for connecting PKCδ signaling with cell proliferation inhibition, apoptosis induction, endothelial permeability, and pathogen entry. This guide translates potency data and the S2-cell infection study into controlled workflows, assay checkpoints, and troubleshooting decisions.
-
PPM-18 Workflows for iNOS and NF-κB Studies
2026-09-07
PPM-18 provides a practical way to connect NF-κB activation with downstream iNOS expression, nitrite release, and inflammatory cytokines in macrophage and sepsis research. This workflow emphasizes solvent control, orthogonal readouts, and careful separation of transcriptional inhibition from direct NOS enzyme inhibition.
-
Candida krusei Apoptosis in Bovine Mammary Cells
2026-09-05
Miao et al. show that the yeast and hypha phases of Candida krusei both trigger apoptosis in bovine mammary epithelial cells, but engage different dominant signaling routes. The study combines morphology, flow cytometry, mitochondrial membrane-potential analysis, TUNEL staining, and immunoblotting to distinguish a mitochondrial mechanism for yeast-phase exposure from a death ligand/receptor mechanism for hypha-phase exposure.
-
Coelenterazine: From Light to Causal Insight
2026-09-04
Coelenterazine is a luminescent enzyme substrate that can connect reporter activity with reactive oxygen species chemistry. This guide presents a causal assay framework inspired by brain–kidney research, helping investigators distinguish biological regulation from substrate, matrix, and detection effects.
-
Polybrene Workflows for Mutant p53 Cell Models
2026-09-04
Polybrene improves lentiviral, retroviral, and selected lipid-mediated DNA delivery workflows, helping researchers build more consistent mutant p53 cell models. This guide connects charge-based viral attachment facilitation with practical assay design for evaluating TRAP-1-driven p53Y220C reactivation while emphasizing controls, cytotoxicity testing, and reproducible optimization.
-
DAPT (GSI-IX): From Notch Biology to Translation
2026-09-03
DAPT (GSI-IX) is more than a γ-secretase inhibitor: it is a mechanistic probe for connecting APP processing, Notch signaling, disease biology, and emerging human sensory-neuron models. This thought-leadership guide outlines how translational researchers can use DAPT rigorously while avoiding overinterpretation.
-
From Cartilage Biology to Smarter Cy5.5 Imaging
2026-09-03
A translational framework for using Cy5.5 NHS ester (non-sulfonated) to track biomolecule and nanoparticle behavior in bioadhesive hydrogel systems inspired by a new aged osteoarthritis study.
-
Tolazoline: From Receptor Blockade to Translation
2026-09-02
Tolazoline is more than a conventional α2-adrenergic receptor antagonist: its ability to interrogate presynaptic airway control and ATP-sensitive potassium channel activity makes it a useful translational probe. This article connects equine airway physiology with islet biology, experimental design, and evidence-based positioning for pharmacological research.
-
Epinephrine Bitartrate: Research Workflows
2026-09-01
Epinephrine Bitartrate enables controlled activation of α- and β-adrenergic receptors across cell, ex vivo, and translational studies. This workflow guide connects concentration design with pharmacokinetic timing, intranasal-versus-intramuscular comparisons, and practical troubleshooting.
-
L-Phenylephrine in Adrenergic α1A Assays
2026-09-01
L-Phenylephrine provides a practical α1A-focused tool for connecting receptor activation with vasoconstriction, cardiomyocyte stress responses, and neural progenitor assays. This workflow-oriented guide shows how to select concentrations, build controls, interpret sex-dependent cardiovascular findings, and troubleshoot unstable or nonspecific results.
-
Deuterated Tetrazole CYP51 Inhibitor: V23 Findings
2026-08-31
A 2025 European Journal of Medicinal Chemistry study used triazole-to-tetrazole replacement, deuteration, and carbonyl incorporation to develop new CYP51 inhibitors. The lead compound V23 combined broad antifungal activity, activity against resistant fungi, anti-biofilm effects, low cellular toxicity, and significant in vivo efficacy, while reducing inhibition of human CYP enzymes relative to the parent compound A33.
-
EdU Cell Proliferation Kit for S-Phase Studies
2026-08-31
The EdU Cell Proliferation Kit converts DNA synthesis into a sensitive, non-radioactive TMB readout for cell-cycle research, genotoxicity testing, and pharmacodynamic drug evaluation. Its click-chemistry workflow is particularly useful for validating proliferation mechanisms identified by transcriptomic studies, including ARL4C-driven fibroblast-like synoviocyte behavior in rheumatoid arthritis.
-
Axitinib Workflows for VEGF Signaling Assays
2026-08-30
A practical guide to using Axitinib (AG 013736) across VEGF pathway, endothelial viability, and tumor-response experiments. The workflow separates pathway blockade from growth arrest and cell death, improving interpretation of angiogenesis inhibition assays and cancer biology research.
-
Tiamulin (Thiamutilin): Mechanism and Evidence
2026-08-29
Tiamulin, also called Thiamutilin, is a pleuromutilin antibiotic used mainly in veterinary infectious-disease control. Its 50S ribosome binding, strain-dependent activity, pharmacokinetic targets, residue limits, and emerging anti-inflammatory research define both its utility and its boundaries.